HB 2716 – Oregon

Status: Inactive / Dead
Year Introduced: 2023
Link: https://olis.oregonlegislature.gov/liz/2023R1/Measures/Overview/HB2716

Prohibits specified practices by insurers and pharmacy benefit managers in reimbursing cost of prescription drugs. May not discriminate against a 340B pharmacy in a manner that prevents or interferes with an enrollee’s choice to receive drugs from the pharmacy by reimbursing a 340B pharmacy less than any other network pharmacy or imposing a fee, charge-back or other adjustment on a claim for reimbursement based on a pharmacy’s status as a 340B pharmacy.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found